Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study.
Bacsur P, Shaham D, Serclova Z, Resál T, Farkas B, Sarlós P, Miheller P, Maharshak N, Zemel M, Shitrit A, Bálint A, Fábián A, Bor R, Bősze Z, Ivány E, Szepes Z, Farkas K, Tóth I, Lázár G, Vlkova K, Tremerova A, Zuskova P, Ábrahám S, Molnár T. Bacsur P, et al. Among authors: balint a. Aliment Pharmacol Ther. 2024 Oct 28. doi: 10.1111/apt.18359. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39468719
Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R, Farkas K, Bálint A, Szucs M, Ábrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T. Bor R, et al. Among authors: balint a. Scand J Gastroenterol. 2015 Feb;50(2):182-7. doi: 10.3109/00365521.2014.936033. Epub 2014 Nov 11. Scand J Gastroenterol. 2015. PMID: 25384713
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.
Bor R, Fábián A, Matuz M, Szepes Z, Farkas K, Miheller P, Szamosi T, Vincze Á, Rutka M, Szántó K, Bálint A, Nagy F, Milassin Á, Tóth T, Zsigmond F, Bajor J, Müllner K, Lakner L, Papp M, Salamon Á, Horváth G, Sarang K, Schäfer E, Sarlós P, Palatka K, Molnár T. Bor R, et al. Among authors: balint a. Expert Opin Biol Ther. 2020 Feb;20(2):205-213. doi: 10.1080/14712598.2020.1699529. Epub 2019 Dec 6. Expert Opin Biol Ther. 2020. PMID: 31782939
Efficacy, tolerability and safety of a split-dose bowel cleansing regimen of magnesium citrate with sodium picosulfate - a phase IV clinical observational study.
Bor R, Matuz M, Fabián A, Szepes Z, Szántó K, Farkas K, Rutka M, Milassin Á, Pigniczki D, Bálint A, Tóth T, Molnár T. Bor R, et al. Among authors: balint a. Rev Esp Enferm Dig. 2021 Sep;113(9):635-642. doi: 10.17235/reed.2020.7073/2020. Rev Esp Enferm Dig. 2021. PMID: 33371690 Free article. Clinical Trial.
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.
Bacsur P, Matuz M, Resál T, Miheller P, Szamosi T, Schäfer E, Sarlós P, Iliás Á, Szántó K, Rutka M, Bálint A, Milassin Á, Fábián A, Bor R, Szepes Z, Molnár T, Farkas K. Bacsur P, et al. Among authors: balint a. Therap Adv Gastroenterol. 2022 Dec 26;15:17562848221144349. doi: 10.1177/17562848221144349. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36600684 Free PMC article.
310 results